Phathom Pharmaceuticals, Inc. (PHAT)
$7.25+1.68%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $578M
- Beta
- 0.51
- P/E (TTM)
- -5.30
- Short % float
- 15.71%
- Days to cover
- 7.4
- SI change
- -0.5%
- 1W
- +4.77%
- 1M
- -13.38%
- vs SPY 1W
- +3.61%
- vs SPY 1M
- -16.37%
Industry peers
FMP comparable companies · ranked by market cap
- KODBUYKodiak Sciences Inc.$5.9BBULLQ 42$94.45+5.95%
- NRIXSELLNurix Therapeutics, Inc.$2.4BBEARQ 11$22.99+0.63%
- URGNSELLUroGen Pharma Ltd.$2.0BCRISISQ 21$41.40-0.41%
- XNCRSELLXencor, Inc.$1.8BRECOVERYQ 15$24.84+0.53%
- SEPNSELLSepterna Inc$1.7BRECOVERYQ 28$37.71+3.98%
- ANABSELLAnaptysBio, Inc.$1.4BCRISISQ 25$48.53-0.56%
- BCAXSELLBicara Therapeutics Inc. Common Stock$1.2BCRISISQ -9$17.63+1.39%
- SANASELLSana Biotechnology, Inc.$804MCRISISQ -5$2.89+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 49
- VALUE
- 26
- GROWTH
- 37
- GARP
- 88
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC15.4%
REV YoY-
ROE25.7%
EPS YoY-
ROA-30.3%
GROSS83
OP-17
NET-41
[VALUATION]
P/E TTM-5.30
P/E FWD9.84
SECTOR PE20.47
INDUSTRY PE13.95
P/B-1.65
P/FCF-
EV/EBITDA-15.17
EV/EBIT-
PEG0.14
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.92
ND/EBITDA-
BETA0.51
